This content is machine translated Aspirin-free strategy after PCI No reduction in bleeding (STOPDAPT-3 study) No ESC Congress without new studies on antithrombotic therapy after percutaneous coronary intervention. Recently, monotherapy with a P2Y12 blocker has increasingly emerged as an attractive alternative to dual antiplatelet therapy…
View Post 8 min This content is machine translated Percutaneous coronary intervention (PCI) Benefits of complete revascularization in elderly patients The benefit of complete revascularization in older patients (≥75 years) with myocardial infarction and multivessel disease is still unclear. At the ESC Congress, however, the results of the FIRE study…
View Post 8 min This content is machine translated Percutaneous coronary intervention How to post-treat after PCI? The type and duration of combined antithrombotic therapy vary. Decisive factors are the clinical setting (stable CHD vs. ACS), the need for additional anticoagulation (e.g., atrial fibrillation), and the patient-specific…
